The Physician Fee Schedule Was Not Built for High-Cost Supplies and Equipment.
health policy and economics
interventional radiology
medicare reimbursement
payment system
physician fee schedule
radiation oncology
vascular surgery
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
received:
26
07
2024
accepted:
26
08
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
28
8
2024
Statut:
epublish
Résumé
As reimbursement from the Medicare Physician Fee Schedule (PFS) continues to decline, cuts to practice expense relative value units disproportionately impact office-based interventionalists and private practices that rely on high-cost equipment. For 195 codes, specialties such as radiation oncology, vascular surgery, and interventional radiology are paid at rates less than their direct costs calculated by the Centers for Medicare and Medicaid Services itself. While reimbursement in the office-based setting continues to decline, high-cost hospital settings receive more payment for the same services. This disparity aligns with trends in care moving to the hospital setting and practice consolidation, resulting in increased costs to the healthcare system and decreased access to care. The current PFS is outdated, and the removal of high-cost supplies and equipment from the PFS is a critical step to reform.
Identifiants
pubmed: 39193060
doi: 10.7759/cureus.67931
pmc: PMC11349034
doi:
Types de publication
Editorial
Langues
eng
Pagination
e67931Informations de copyright
Copyright © 2024, Rasmussen et al.
Déclaration de conflit d'intérêts
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Bob Tahara declare(s) personal fees from Boston Scientific. Bob Tahara declare(s) personal fees from Philips. Bob Tahara declare(s) stock/stock options from Provisio Medical. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.